Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BLA Accepted: Novartis Inches Ahead In CAR-T Race With Kite

T-cells attacking cancer_1200x675

Related Content

Kite On Course For FDA Filing On Positive CAR-T Durability Data

Mar 01 2017

Juno Ends JCAR015 Development In ALL, Cementing Third Place CAR-T Position

Mar 02 2017

ASH Ends With Consistent Kite CAR-T Data, Some Hope For Juno

Dec 07 2016

Novartis, Kite Neck-And-Neck In CAR-T Race; Deaths Keep Juno In Third Place

Dec 05 2016

Kite Flies CAR-T Into Asia With Daiichi Sankyo, Fosun Deals

Jan 11 2017

Related Companies

Novartis AG

Kite Pharma, Inc.

Roche Holding AG

Bristol Myers Squibb Company

Additional Topics

Commercial Business Strategies ImmunoOncology Pricing Strategies Regulation BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window